Market Research Logo

Preventive Healthcare Technologies And Services Market Size & Forecast By Technology (Early Detection & Screening, Vaccines, Chronic Disease Management, Advanced Technologies To Reduce Errors), And Trend Analysis From 2013 To 2024

Preventive Healthcare Technologies And Services Market Size & Forecast By Technology (Early Detection & Screening, Vaccines, Chronic Disease Management, Advanced Technologies To Reduce Errors), And Trend Analysis From 2013 To 2024

The global preventive healthcare technologies and services market is expected to reach USD 432.4 billion by 2024, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending.

The growth of this market is attributed to the adoption of advanced technology and development of preventive measures, including vaccines, screening & monitoring devices, and smart devices to reduce medical errors. Growth of the market is also fueled by the factors such as reducing birth rate that is resulting in increase of geriatric population, which is more prone to the chronic diseases.

With the introduction of Human Development Index (HDI) ratings since 2010, all countries are engaged in the overall development of their country and citizens. Life expectancy has a significant impact on HDI calculations. Governments of the countries have been focusing on improving life expectancy of the people by implementing various programs, including free or affordable vaccination, smoking cessation, and affordable insurance schemes. These programs cause a direct positive impact on the preventable technologies and services space.

A large share of preventive healthcare includes early detection and screening technology. This segment pertains to personalized diagnostic techniques, which has captured the largest share owing to accuracy and availability of the innovative techniques for diagnosis.

Further Key Findings from the Study Suggest:

According to data published by the WHO, the percentage of the total vaccinations in the U.S. has been growing. The vaccinations included those funded by the government as well as the private purchases.

In 2015, the early detection and screening technologies’ segment captured the largest share. The advantages associated with personalized medicine technologies, such as high accuracy and detection of the possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.

With the introduction of advanced technology and growing demand for accurate screening methods, the growth of the early detection and screening is expected to be the fastest during the forecast period.

North American region dominated this space by capturing over the 48.0% of the global market in 2015. This region is anticipated to dominate the market throughout the forecast period. Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, and the presence of a large number of major players in the region.

Growing economies and government initiatives are expected to drive the growth of the Asia Pacific region. The segment is expected to witness a lucrative CAGR over 15% during the forecast period.

Some major players in the consolidated market are McKesson Corporation; Scripto LLC; Omnicell, Inc.; Healthways, Inc.; Alere; Medtronic; GlaxoSmithKline plc; Pfizer, Inc.; and Merck & Co, Inc.


Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation& Scope
3.1.1 Market driver analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Preventive Healthcare Technologies and Services - SWOT Analysis, by Factor (Political & Legal, Economic, & Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Market Categorization 1: Technology Estimates & Trend Analysis
4.1 Preventive Healthcare Technologies and Services Market : Technology Movement Analysis
4.2 Early Detection and Screening Technologies
4.2.1 Early detection and screening technologies market, 2013 - 2024 (USD Million)
4.2.1.1 Automated screening market, 2013 - 2024 (USD Million)
4.2.1.2 Personalized medicine market, 2013 - 2024 (USD Million)
4.2.1.3 Other advanced screening technologies market, 2013 - 2024 (USD Million)
4.2.2 Chronic disease management technologies market, 2013 - 2024 (USD Million)
4.2.2.1 Blood pressure monitors market, 2013 - 2024 (USD Million)
4.2.2.2 Asthma monitors market, 2013 - 2024 (USD Million)
4.2.2.3 Cardiovascular monitors market, 2013 - 2024 (USD Million)
4.2.2.4 Glucose monitors market, 2013 - 2024 (USD Million)
4.2.3 Vaccines market, 2013 - 2024 (USD Million)
4.2.3.1 Infectious diseases vaccine market, 2013 - 2024 (USD Million)
4.2.3.2 Cancer vaccine market, 2013 - 2024 (USD Million)
4.2.3.3 Autism vaccine market, 2013 - 2024 (USD Million)
4.2.3.4 Allergy vaccine market, 2013 - 2024 (USD Million)
4.2.3.5 Other vaccine market, 2013 - 2024 (USD Million)
4.2.4 Advanced technologies to reduce errors market, 2013 - 2024 (USD Million)
4.2.4.1 Electronic prescribing market, 2013 - 2024 (USD Million)
4.2.4.2 Clinical decision support system market, 2013 - 2024 (USD Million)
4.2.4.3 Smart infusion pumps market, 2013 - 2024 (USD Million)
4.2.4.4 Computerized provider order entry system market, 2013 - 2024 (USD Million)
4.2.4.5 Smart packaging market, 2013 - 2024 (USD Million)
4.2.4.6 Automated prescription formulation and dispensing market, 2013 - 2024 (USD Million)
Chapter 5 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application
5.1 Preventive Healthcare Technologies and Services Market Share by Region, 2015 & 2024
5.2 North America
5.2.1 U.S.
5.2.2 Canada
5.3 Europe
5.3.1 UK
5.3.2 Germany
5.4 Asia Pacific
5.4.1 Japan
5.4.2 China
5.5 Latin America
5.5.1 Brazil
5.5.2 Mexico
5.6 MEA
5.6.1 South Africa
5.6.2 Saudi Arabia
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Myriad Genetics, Inc.
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Quest Diagnostics, Inc
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Medtronic
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Alere
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Merck & Co., Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 GlaxoSmithKline plc
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Omnicell, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 McKesson Corporation
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
List of Tables
TABLE 1 North America preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 2 North America early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 3 North America chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 4 North America vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 5 North America advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 6 The U.S. preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 7 The U.S. early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 8 The U.S. chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 9 The U.S. vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 10 The U.S. advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 11 Canada preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 12 Canada early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 13 Canada chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 14 Canada vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 15 Canada advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 16 Europe preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 17 Europe early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 18 Europe chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 19 Europe vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 20 Europe advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 21 UK preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 22 UK early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 23 UK chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 24 UK vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 25 UK advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 26 Germany preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 27 Germany early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 28 Germany chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 29 Germany vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 30 Germany advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 31 Asia Pacific preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 32 Asia Pacific early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 33 Asia Pacific chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 34 Asia Pacific vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 35 Asia Pacific advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 36 Japan preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 37 Japan early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 38 Japan chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 39 Japan vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 40 Japan advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 41 China preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 42 China early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 43 China chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 44 China vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 45 China advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 46 Latin America preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 47 Latin America early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 48 Latin America chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 49 Latin America vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 50 Latin America advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 51 Brazil preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 52 Brazil early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 53 Brazil chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 54 Brazil vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 55 Brazil advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 56 Mexico preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 57 Mexico early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 58 Mexico chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 59 Mexico vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 60 Mexico advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 61 MEA preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 62 MEA early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 63 MEA chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 64 MEA vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 65 MEA advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 66 South Africa preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 67 South Africa early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 68 South Africa chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 69 South Africa vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 70 South Africa advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
TABLE 71 Saudi Arabia preventive healthcare technologies and services market, by product, 2013 - 2024 (USD Million)
TABLE 72 Saudi Arabia early detection and screening technologies market, by product, 2013 - 2024 (USD Million)
TABLE 73 Saudi Arabia chronic disease management technologies market, by product, 2013 - 2024 (USD Million)
TABLE 74 Saudi Arabia vaccines market, by product, 2013 - 2024 (USD Million)
TABLE 75 Saudi Arabia advanced technologies to reduce errors market, by product, 2013 - 2024 (USD Million)
List of Figures
FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Penetration & growth prospect mapping
FIG. 6 SWOT analysis, by factor (Political & legal, economic and technological)
FIG. 7 Porter’s Five Forces Analysis
FIG. 8 Preventive healthcare technologies and services market technology outlook key takeaways
FIG. 9 Preventive healthcare technologies and services market: technology movement analysis
FIG. 10 Early detection and screening technology market, 2013 - 2024 (USD Million)
FIG. 11 Automated screening technology market, 2013 - 2024 (USD Million)
FIG. 12 Personalized medicine technology market, 2013 - 2024 (USD Million)
FIG. 13 Other advanced screening technologies market, 2013 - 2024 (USD Million)
FIG. 14 Chronic diseases management technology market, 2013 - 2024 (USD Million)
FIG. 15 Blood pressure monitors market, 2013 - 2024 (USD Million)
FIG. 16 Asthma monitors market, 2013 - 2024 (USD Million)
FIG. 17 Cardiovascular monitors market, 2013 - 2024 (USD Million)
FIG. 18 Glucose monitors market, 2013 - 2024 (USD Million)
FIG. 19 Vaccines market, 2013 - 2024 (USD Million)
FIG. 20 Infectious Diseases vaccine market, 2013 - 2024 (USD Million)
FIG. 21 Cancer vaccine market, 2013 - 2024 (USD Million)
FIG. 22 Autism Vaccine market, 2013 - 2024 (USD Million)
FIG. 23 Allergy vaccine market, 2013 - 2024 (USD Million)
FIG. 24 Other vaccine market, 2013 - 2024 (USD Million)
FIG. 25 Advanced technologies to reduce errors market, 2013 - 2024 (USD Million)
FIG. 26 Electronic prescribing market, 2013 - 2024 (USD Million)
FIG. 27 Clinical decision support system market, 2013 - 2024 (USD Million)
FIG. 28 Smart infusion pumps market, 2013 - 2024 (USD Million)
FIG. 29 Computerized provider order entry system market, 2013 - 2024 (USD Million)
FIG. 30 Smart packaging and automated prescription formulation and dispensing market, 2013 - 2024 (USD Million)
FIG. 31 Regional market place: Key takeaways
FIG. 32 Regional outlook, 2015 & 2024
FIG. 33 Strategy framework
FIG. 34 Participant categorization

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report